Key Findings:  6 pre-clinical trials showed neuro-protective effects after treatment with CBD; 3 found anti-dyskinetic induced by CBD; 3 human trials tested CBD in PD patients: an open-label study, a case series, and a randomized controlled trial—all reported therapeutic effects of CBD on non-motor symptoms.
Type of Study:  Meta-analysis
Study Result:  Positive
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III